Dmitry N. Shcherbinin

Gamaleya Str. 18, 123098
Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens.

Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens.

Journal: Vaccines

Published: November 05, 2025

Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge.

Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge.

Journal: Vaccines

Published: October 27, 2025

Development, study, and comparison of models of cross-immunity to the influenza virus using statistical methods and machine learning.

Development, study, and comparison of models of cross-immunity to the influenza virus using statistical methods and machine learning.

Journal: Voprosy virusologii

Published: July 26, 2024

Identification of the Clinical Isolate CCGC 19/16 as Bacillus cytotoxicus

Identification of the Clinical Isolate CCGC 19/16 as Bacillus cytotoxicus

Journal: Molekuliarnaia biologiia

Published: April 23, 2024

Mathematical model for assessing the level of cross-immunity between strains of influenza virus subtype H3N2

Mathematical model for assessing the level of cross-immunity between strains of influenza virus subtype H3N2

Journal: Voprosy virusologii

Published: June 14, 2023

Latex Agglutination as an Alternative to the Hemagglutination Reaction of Influenza Viruses

Latex Agglutination as an Alternative to the Hemagglutination Reaction of Influenza Viruses

Journal: Molekuliarnaia biologiia

Published: December 05, 2022

Identification of Clinical Isolates of the Bacillus cereus Group and Their Characterization by Mass Spectrometry and Electron Microscopy

Identification of Clinical Isolates of the Bacillus cereus Group and Their Characterization by Mass Spectrometry and Electron Microscopy

Journal: Molekuliarnaia biologiia

Published: November 14, 2022

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.

Journal: The Lancet regional health. Europe

Published: November 08, 2021

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses.

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses.

Journal: Acta naturae

Published: June 18, 2021

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection.

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection.

Journal: Acta naturae

Published: June 18, 2021

Ebola virus (Filoviridae: Ebolavirus: Zaire ebolavirus): fatal adaptation mutations

Ebola virus (Filoviridae: Ebolavirus: Zaire ebolavirus): fatal adaptation mutations

Journal: Voprosy virusologii

Published: March 07, 2021

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

Journal: Lancet (London, England)

Published: December 31, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026